10-49738261-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_018245.3(OGDHL):c.2321G>A(p.Gly774Asp) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000169 in 1,612,580 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018245.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OGDHL | NM_018245.3 | c.2321G>A | p.Gly774Asp | missense_variant, splice_region_variant | 18/23 | ENST00000374103.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OGDHL | ENST00000374103.9 | c.2321G>A | p.Gly774Asp | missense_variant, splice_region_variant | 18/23 | 1 | NM_018245.3 | P1 | |
OGDHL | ENST00000419399.4 | c.2150G>A | p.Gly717Asp | missense_variant, splice_region_variant | 17/22 | 2 | |||
OGDHL | ENST00000432695.2 | c.1694G>A | p.Gly565Asp | missense_variant, splice_region_variant | 16/21 | 2 | |||
OGDHL | ENST00000490844.1 | n.1239G>A | non_coding_transcript_exon_variant | 1/5 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.000112 AC: 17AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000995 AC: 25AN: 251242Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135812
GnomAD4 exome AF: 0.000175 AC: 256AN: 1460426Hom.: 0 Cov.: 31 AF XY: 0.000158 AC XY: 115AN XY: 726540
GnomAD4 genome ? AF: 0.000112 AC: 17AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74316
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 11, 2023 | The c.2321G>A (p.G774D) alteration is located in exon 18 (coding exon 17) of the OGDHL gene. This alteration results from a G to A substitution at nucleotide position 2321, causing the glycine (G) at amino acid position 774 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at